These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15220534)

  • 1. Analysis of checkpoint responses to histone deacetylase inhibitors.
    Beamish H; Warrener R; Gabrielli BG
    Methods Mol Biol; 2004; 281():245-59. PubMed ID: 15220534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors induce mitotic slippage.
    Stevens FE; Beamish H; Warrener R; Gabrielli B
    Oncogene; 2008 Feb; 27(10):1345-54. PubMed ID: 17828304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints.
    Warrener R; Beamish H; Burgess A; Waterhouse NJ; Giles N; Fairlie D; Gabrielli B
    FASEB J; 2003 Aug; 17(11):1550-2. PubMed ID: 12824307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint.
    Magnaghi-Jaulin L; Eot-Houllier G; Fulcrand G; Jaulin C
    Cancer Res; 2007 Jul; 67(13):6360-7. PubMed ID: 17616695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyzing cell cycle checkpoints after ionizing radiation.
    Xu B; Kastan MB
    Methods Mol Biol; 2004; 281():283-92. PubMed ID: 15220537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner.
    Noh EJ; Lim DS; Jeong G; Lee JS
    Biochem Biophys Res Commun; 2009 Jan; 378(3):326-31. PubMed ID: 19038231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors disrupt the mitotic spindle assembly checkpoint by targeting histone and nonhistone proteins.
    Gabrielli B; Brown M
    Adv Cancer Res; 2012; 116():1-37. PubMed ID: 23088867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET.
    Brest P; Gustafsson M; Mossberg AK; Gustafsson L; Duringer C; Hamiche A; Svanborg C
    Cancer Res; 2007 Dec; 67(23):11327-34. PubMed ID: 18056459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.
    Qiu L; Burgess A; Fairlie DP; Leonard H; Parsons PG; Gabrielli BG
    Mol Biol Cell; 2000 Jun; 11(6):2069-83. PubMed ID: 10848630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T; Takai N; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EBNA-3 gene family proteins disrupt the G2/M checkpoint.
    Krauer KG; Burgess A; Buck M; Flanagan J; Sculley TB; Gabrielli B
    Oncogene; 2004 Feb; 23(7):1342-53. PubMed ID: 14716295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins.
    Ouwehand K; de Ruijter AJ; van Bree C; Caron HN; van Kuilenburg AB
    FEBS Lett; 2005 Feb; 579(6):1523-8. PubMed ID: 15733867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting.
    Ree AH; Stokke T; Bratland A; Patzke S; Nome RV; Folkvord S; Meza-Zepeda LA; Flatmark K; Fodstad O; Andersson Y
    Anticancer Res; 2006; 26(3A):1909-16. PubMed ID: 16827124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy.
    Vogel C; Kienitz A; Hofmann I; Müller R; Bastians H
    Oncogene; 2004 Sep; 23(41):6845-53. PubMed ID: 15286707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.
    Ryu JK; Lee WJ; Lee KH; Hwang JH; Kim YT; Yoon YB; Kim CY
    Cancer Lett; 2006 Jun; 237(1):143-54. PubMed ID: 16009488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FACS-based detection of phosphorylated histone H3 for the quantitation of mitotic cells.
    Taylor WR
    Methods Mol Biol; 2004; 281():293-9. PubMed ID: 15220538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
    Chung YL; Lee MY; Pui NN
    Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.